Delivery Order SPE2DB25D7068-SPE2DB25FTYAE
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,278.36 to AmerisourceBergen Drug Corp for Shingrix vial kits, with an ultimate completion date of September 8, 2025. This firm fixed-price delivery order, awarded on September 5, 2025, represents a non-competitive set-aside contract and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for the prevention of herpes zoster (shingles) in adults, making...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,783.60 to AmerisourceBergen Drug Corp for Shingrix vial kits on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for the prevention of herpes zoster (shingles) and is a...
- The Defense Logistics Agency awarded a delivery order valued at $2,278.36 to AmerisourceBergen Drug Corp for Shingrix vial kits on July 16, 2025, with completion targeted for July 17, 2025. This competitively awarded, firm fixed price delivery order represents a small-value pharmaceutical procurement executed through AmerisourceBergen's existing contract vehicle with DLA. The work will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Shingrix is a recombinant...
- The Defense Logistics Agency awarded a $14,012.49 delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with an ultimate completion date of August 18, 2025. This contract represents a firm fixed-price delivery order issued under a competitive procurement with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for the prevention of herpes zoster (shingles) in...
- The Defense Logistics Agency awarded a delivery order valued at $10,533.22 to AmerisourceBergen Drug Corp for Shingrix vial kits on September 11, 2025, with completion scheduled for September 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for prevention of herpes zoster (shingles) and post-herpetic neuralgia in...
- The Defense Logistics Agency awarded a delivery order valued at $3,417.54 to AmerisourceBergen Drug Corp for Shingrix vial kits, a vaccine product for the prevention of herpes zoster (shingles) in adults. The contract was awarded on September 4, 2025, with an ultimate completion date of September 5, 2025, and is structured as a firm fixed-price delivery order with no set-aside designation. Performance will be completed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits with a ceiling value of $1,139.18. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of September 8, 2025, and was issued on September 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine indicated for the prevention of herpes zoster...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with a ceiling value of $3,560.82 and an ultimate completion date of August 28, 2025. This firm fixed-price contract, awarded on August 27, 2025, represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for the prevention of...
- The Defense Logistics Agency awarded a $11,391.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with a completion date of June 6, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion vehicle designated SPE2DX and running through December 2026. The order will be fulfilled from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,000.99 to AmerisourceBergen Drug Corp for Shingrix vial kits, with an ultimate completion date of July 28, 2025. This is a firm fixed price delivery order with no set-aside designation, issued on July 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Shingrix is a recombinant zoster vaccine used for the prevention of herpes zoster (shingles)...
- SPE2DB25D7068Indefinite Delivery Contract
- SPE2DB25D7068-SPE2DB25FTYAEDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,278.36 to AmerisourceBergen Drug Corp for Shingrix vial kits, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price delivery order was issued on September 16, 2025, with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for the prevention of herpes zoster (shingles) and is a standard immunization provided through military and federal healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The arrangement demonstrates the company's established capability to meet federal procurement requirements through the DLA Medical Supply Chain and to serve customers including the Defense Health Agency and U.S. Coast Guard across multiple therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/16/25 |